Vasco F. J. Cumbe

Prof. Dr. Vasco F. J. Cumbe

Direcção Científica e Pedagógica, Beira Central Hospital, Beira, Sofala, Mozambique
+3
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2020 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
VCVasco F. J. Cumbe
Vasco F. J. Cumbe
AMAlberto Muanido
Alberto Muanido
MMMaria Nélia Manaca
Maria Nélia Manaca
HFHélder Fumo
Hélder Fumo
PCPedro Chiruca
Pedro Chiruca
BWBradley H. Wagenaar
Bradley H. Wagenaar
Background: Depression is one of the leading causes of disability in Mozambique; however, few patients with depression are identified in primary care. To our knowledge, there are no validated tools for depression screening in Mozambique. The aim of this study was to validate the Patient Health Questionnaire-9 (PHQ-9) for use in primary care settings in Mozambique. Methods: The PHQ-9 was adapted using a structured multi-phase process led by a team of bilingual experts followed by a review by lay individuals and pilot-testing including cognitive interviews. The final Mozambican PHQ-9 (PHQ-9-MZ) was applied among 502 individuals randomly selected from antenatal, postpartum, and general outpatient consultations in three Ministry of Health primary healthcare clinics in Sofala Province, Mozambique. The PHQ-9-MZ was evaluated against the MINI 5.0-MZ as a gold standard diagnostic tool. Results: The majority of participants were female (74%), with a mean age of 28. Using the MINI 5.0-MZ, 43 (9%) of the sample tested positive for major depressive disorder. Items of the PHQ-9-MZ showed good discrimination and factor loadings. One latent factor of depression explained 54% of the variance in scores. Questions 3 (sleep) and 5 (appetite) had the lowest item discrimination and factor loadings. The PHQ-9-MZ showed good internal consistency, with a Cronbach’s alpha of 0.84, and an area under the receiver operating characteristic curve (AUROC) of 0.81 (95% CI: 0.73, 0.89). The PHQ-2-MZ had an AUROC of 0.78 (95% CI: 0.70, 0.85). Using a cut-point of ≥9, the PHQ-9-MZ had a sensitivity of 46.5% and a specificity of 93.5%. Using a cut-point of ≥2, the PHQ-2-MZ had a sensitivity of 74.4% and a specificity of 71.7%. Increasing the cut-point to ≥3, the PHQ-2-MZ has a sensitivity of 32.6% and a specificity of 94.6%. Conclusions: The PHQ-9-MZ and PHQ-2-MZ emerge as two valid alternatives for screening for depression in primary health care settings in Mozambique. Depending on program needs and weighing the value of minimizing false positives and false negatives, the PHQ-9-MZ can be employed with cut-points ranging from ≥8 to ≥11, and the PHQ-2-MZ with cut-points ranging from ≥2 to ≥3.

29 May 2019 in International Journal of Mental Health Systems
Verified
Journal Article
Open access
PDF file
PSPalmira Fortunato Dos Santos
Palmira Fortunato Dos Santos
VCVasco F. J. Cumbe
Vasco F. J. Cumbe
MGMaria Lídia Gouveia
Maria Lídia Gouveia
CFCapucine de Fouchier
Capucine de Fouchier
DTDirk Teuwen
Dirk Teuwen
TDTarun Dua
Tarun Dua
Epilepsy remains the most frequent diagnosis in Psychiatric and Mental Health Services in Mozambique. Because it is a major concern, in 2013 a Program for “Reducing the Epilepsy Treatment gap” was launched in 16 districts of five provinces covering a population of over 1.9 million. Using the WHO Mental Health Gap Program (mhGAP), a pilot Program was developed to provide effective quality care and treatment for people with epilepsy at primary health care level. Implementation was against a background of a shortage of human resources trained to address epilepsy and difficulties in the availability of antiepileptic medicines. The first step for implementation was advocacy from the Government level to relevant stakeholders in the community. mhGAP training materials were translated and adapted to the local context. Non-specialists health providers and community health workers were trained and supervised regularly. Population awareness raising and community involvement were key for acceptance of the Program. After 4 years of implementation, 177 health professionals and 1161 community health workers were trained and ensured services delivery for people living with epilepsy (PwE). The implementation led to 89,869 consultations, representing an increase of 67% since the Program’s inception. From 2015 to 2017 a total of 13,563 new cases were attended and the treatment gap was reduced from 99 to 96%. More than 60% of the new cases are children and adolescents. Awareness actions reached more than 14,000 people per year using all available broadcast means. Preliminary positive results were used as evidence for the Ministry of Health (MoH) to increase the purchase of antiepileptic drugs and improve delivery at district level. mhGAP is an important tool for reducing the treatment gap in low-income countries. Adapting guidelines to the country context and involving community stakeholders are key for Program sustainability. As in other settings, the strategy was cost-effective resulting in an increase in new cases and follow-up consultations. Implementation of an adapted mhGAP strategy and the involvement of community stakeholders and commitment of the MoH resulted in significant increase in the number of PwE attending outpatient services in primary health care facilities.

1 June 2016 in Psychiatric Services
Verified
Journal Article
Closed access
BWBradley H. Wagenaar
Bradley H. Wagenaar
VCVasco F. J. Cumbe
Vasco F. J. Cumbe
MRManuela Raunig-Berhó
Manuela Raunig-Berhó
DRDeepa Rao
Deepa Rao
BKBrandon A. Kohrt
Brandon A. Kohrt
KSKenneth Sherr
Kenneth Sherr

15 June 2015 in Global Health Action
Verified
Journal Article
Open access
PDF file
BWBradley H. Wagenaar
Bradley H. Wagenaar
ASAndy Stergachis
Andy Stergachis
DRDeepa Rao
Deepa Rao
RHRoxanne Hoek
Roxanne Hoek
VCVasco F. J. Cumbe
Vasco F. J. Cumbe
KSKenneth Sherr
Kenneth Sherr
The availability of essential medicines for mental healthcare in Sofala, Mozambique

17 July 2019 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
WTwith input from the INCOMAS Study Team
with input from the INCOMAS Study Team
SHSheldon Halsted
Sheldon Halsted
KÁKristjana H. Ásbjörnsdóttir
Kristjana H. Ásbjörnsdóttir
BWBradley H. Wagenaar
Bradley H. Wagenaar
VCVasco F. J. Cumbe
Vasco F. J. Cumbe
KSKenneth Sherr
Kenneth Sherr

1 December 2019 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
AWAnjuli D. Wagner
Anjuli D. Wagner
SGSarah Gimbel
Sarah Gimbel
KÁKristjana H. Ásbjörnsdóttir
Kristjana H. Ásbjörnsdóttir
PCPeter Cherutich
Peter Cherutich
JCJoana Coutinho
Joana Coutinho
KSKenneth Sherr
Kenneth Sherr
Background: Cascades have been used to characterize sequential steps within a complex health system and are used in diverse disease areas and across prevention, testing, and treatment. Routine data have great potential to inform prioritization within a system, but are often inaccessible to frontline health care workers (HCWs) who may have the greatest opportunity to innovate health system improvement. Methods: The cascade analysis tool (CAT) is an Excel-based, simple simulation model with an optimization function. It identifies the step within a cascade that could most improve the system. The original CAT was developed for HIV treatment and the prevention of mother-to-child transmission of HIV. Results: CAT has been adapted 7 times: to a mobile application for prevention of mother-to-child transmission; for hypertension screening and management and for mental health outpatient services in Mozambique; for pediatric and adolescent HIV testing and treatment, HIV testing in family planning, and cervical cancer screening and treatment in Kenya; and for naloxone distribution and opioid overdose reversal in the United States. The main domains of adaptation have been technical—estimating denominators and structuring steps to be binary sequential steps—as well as logistical—identifying acceptable approaches for data abstraction and aggregation, and not overburdening HCW. Discussion: CAT allows for prompt feedback to HCWs, increases HCW autonomy, and allows managers to allocate resources and time in an equitable manner. CAT is an effective, feasible, and acceptable implementation strategy to prioritize areas most requiring improvement within complex health systems, although adaptations are being currently evaluated.